Fund moves

Stryker Corporation (SYK)Banque Transatlantique SA added to its stake +5,643 shares

Banque Transatlantique SA added to its stake in Stryker Corporation, per its Q2 2026 13F.

184K
Shares reported · +5,643 vs prior quarter
1.3%
Disclosed portfolio weight
$61.4M
Reported value
Holdings as of
Jun 30, 2026
Filed
Jul 30, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Jun 26, 2019Insider · Their first buy on recordDirector purchased ~$13K of SYK shares in the open market
  2. Sep 12, 2019Insider · Bought outside the usual windowDirector purchased ~$2.4K of SYK shares in the open market
  3. May 12, 2020InsiderDirector purchased ~$7K of SYK shares in the open market
  4. Jun 12, 2020InsiderDirector purchased ~$557 of SYK shares in the open market
  5. Nov 22, 2022Insider · First insider buy since Jul 2020Director purchased ~$4.1K of SYK shares in the open market
  6. Mar 27, 2026CongressDisclosed sale of SYK — reported range $15,001 - $50,000
  7. Jun 2, 2026CongressDisclosed partial sale of SYK — reported range $1,001 - $15,000
  8. Jun 17, 2026Federal contract · $1.8M obligatedDepartment of Veterans Affairs awarded Stryker Corporation: $1.75M obligated to date
  9. Jun 30, 2026Federal contract · $5.6M obligatedDepartment of Veterans Affairs awarded Stryker Corporation: $5.6M obligated to date
  10. Jul 16, 2026Federal contract · $1.2M obligatedDepartment of Veterans Affairs awarded Stryker Corporation: $1.19M obligated to date
  11. Jul 22, 2026CongressDisclosed partial sale of SYK — reported range $1,001 - $15,000
  12. Jul 30, 2026Company filing · Form 8-K · ResultsReported its results
  13. Jul 30, 2026FDAFDA device clearance: AIR+ All-Inside Meniscal Repair Device, Curved Up;AIR+ All-Inside Meniscal Repair Device, Curved Down
  14. Jul 30, 2026FDARecall: SCORPIO C-DOME PATELLA 73-2710 73-2910 SCORPIO U-DOME PATELLA 73-3110 73-3508 73-3708 73-3710 73-3910 Orthopaedic implant components manufactured from UHMWPE (…
  15. Jul 30, 2026FDARecall: ABG I ACETABULAR INSERT HOODED 28mm ID X 48mm C-M079-2-801 ARC2F ACETABULAR INSERT 48/50/52mm OD x 28mm ID C-M071-6-700 ARC2F ACETABULAR INSERT 50mm OD x 28mm…
  16. Jul 30, 2026FDARecall: ACETABULAR CUP UHMWPE 61-3258 ALL POLY CONSTRAINED INSERT 44MM 69-2244 ALL POLY CONSTRAINED INSERT 46MM 69-2246 ALL POLY CONSTRAINED INSERT 48MM 69-2248 ALL PO…
  17. Jul 30, 2026FDARecall: OMNIFIT SERIES I ACET. INSERT 10¿ 22mm ID Catalog No. 2001-2246 Orthopaedic implant components manufactured from UHMWPE (polyethylene)
  18. Jul 30, 2026FDARecall: TRIDENT 0¿ POLY INSERT 28mm ID 620-00-28D Orthopaedic implant components manufactured from UHMWPE (polyethylene)
  19. Jul 30, 2026FDARecall: ALL POLY CONSTRAINED INSERT 54MM 69-2854 NRG KNEE CR 82-2-0512 82-2-0518 82-2-0912 NRG KNEE P/S 82-3-0318 SCORPIO + MOBILE BEARING PCS 78-5-0910 SCORPIO C-DOME…

What came next

  1. Aug 6, 2026FDAFDA device clearance: Triathlon® Knee System; Triathlon® Hinge Knee System; Scorpio® Total Knee System
  2. Aug 18, 2026Insider · 2 peopleInsiders: 9 sales (~$101.0M)
  3. Aug 19, 2026FDARecall: REF:2B5ST Ethicon Endo-Surgery, Inc. XCEL BLADELESS TROCAR W/OPTIVIEW TECHNOLOGY & SLEEVE 5MM X 75MM
  4. Aug 19, 2026FDARecall: REF:B12LT Ethicon Endo-Surgery, Inc. XCEL BLADELESS TROCAR W/STABILITY SLEEVE 12X100MM
  5. Aug 19, 2026FDARecall: REF:B11LT Ethicon Endo-Surgery, Inc. XCEL BLADELESS TROCAR W/STABILITY SLEEVE 11X100MM
  6. Aug 19, 2026FDARecall: REF:B5ST Ethicon Endo-Surgery, Inc. XCEL BLADELESS TROCAR W/STABILITY SLEEVE 5X75MM
  7. Aug 19, 2026FDARecall: REF:B5LT Ethicon Endo-Surgery, Inc. XCEL BLADELESS TROCAR W/STABILITY SLEEVE 5X100MM
  8. Aug 19, 2026FDARecall: REF:2B5LT Ethicon Endo-Surgery, Inc. XCEL BLADELESS TROCAR W/OPTIVIEW TECHNOLOGY & SLEEVE 5MM X 100MM
  9. Aug 19, 2026Insider · 1 personInsiders: 12 sales (~$17.0M)
  10. Aug 21, 2026InsiderOfficer sold ~$145K of SYK shares in the open market
  11. Sep 15, 2026Federal contract · $2.6M obligatedDepartment of Veterans Affairs awarded Stryker Corporation: $2.58M obligated to date
  12. Sep 16, 2026Federal contract · $1.7M obligatedDepartment of Veterans Affairs awarded Stryker Corporation: $1.73M obligated to date
  13. Sep 17, 2026FDAFDA device clearance: Neptune® SafeAir® 10ft Smoke Evacuation Pencil, Square Coated, 70mm Blade, Push Button Switch (0703-046-100);Neptune® SafeAir® 10ft Smoke Evacuation Pencil, Sq…
  14. Oct 6, 2026Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“Stryker Corporation (the “Company”) announced on October 6, 2026 that Kevin A. Lobo will resign from his role as Chief Executive Officer (“CEO”) of the Company on December 31, 2026 and transition to the role of Executive Chair of the Board of Directors of the Company (the “Board”), effective January 1, 2027 (the “CEO Transition”) and that Spencer S. Stiles, who currently serves as President and Chief Operating…”
View the official recordSEC Form 13F-HR

How to read SEC Form 13F-HR

Form 13F is the quarterly report in which investment managers that oversee $100 million or more list the US-listed stocks and some other securities they held on the last day of the quarter.

Full guide: What is an SEC Form 13F?

What else is on file for Stryker Corporation

For Stryker Corporation, OQRO holds 27 insider filings (SEC Form 4 or Form 144), 3 Congress trade reports, 67 fund holdings reports (13F) and 3 federal contract awards dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its SYK page.

How this filing works

Other disclosures at Stryker Corporation

Everything OQRO holds on this company is on its SYK page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data